Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-15

Clinical Trial Update: HeartMate 3™ CE Mark Clinical Investigation Plan [NA]

View source ↗

Summary

Clinical trial update for HeartMate 3 CE Mark Investigational Plan; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HeartMate 3

Snippet

Sponsor: Abbott Medical Devices | Conditions: Advanced Refractory Left Ventricular Heart Failure | NA | Status: COMPLETED | Results posted: 2018-02-15